CITADEL ADVISORS LLC: FGM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITADEL ADVISORS LLC on FGM, newest first. How the timeline and the estimate are built.
CITADEL ADVISORS LLC held 11,448 FGM shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.
the latest 13F is the newest step
- period ended2026-06-3013F/A 11,448 sharesChange vs previous 13F -44,079 shares
<0.01% of the 13F portfolio, value $726,597.
13F-HR/A 0001104659-26-104387 filed by CITADEL ADVISORS LLC
Accepted , ingested - period ended2026-03-3113F 55,527 sharesChange vs previous 13F +55,527 shares
<0.01% of the 13F portfolio, value $3,332,614.
13F-HR 0001104659-26-062477 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 0 sharesChange vs previous 13F -10,181 shares
13F-HR 0001104659-26-016408 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 10,181 sharesChange vs previous 13F -2,243 shares
<0.01% of the 13F portfolio, value $598,720.
13F-HR 0001104659-25-112514 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 12,424 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $700,217.
13F-HR 0001104659-25-078555 filed by CITADEL ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).